Liraglutide treatment increased GLP-1 + and bihormonal insulin + glucagon + cells (Figure 5, AD
On GLP-1, sometimes its better to get little doses of protein throughout the day
Additionally, systemic changes in the body, such as low-level inflammation, disturbances in neurohumoral systems, and dysregulation of the autonomic nervous system, are common in many cerebral and somatic conditions [102, 103]
When you take a GLP-1 agonist , the appetite suppression can be profound
For patients interested in exploring whether microdosing GLP-1 aligns with their health goals, the first step is a comprehensive consultation with a provider who can assess candidacy and develop a personalized treatment plan